Case 1 SBA Flashcards

1
Q

Indications for lisinopril

A

Take by mouth, initially 10mg once daily. Usual maintenance 20mg once daily, maximum 80mg daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraindications for lisinopril

A

Patients with or family history of angioedema, patients with diabetes mellitus in combination with aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for losartan

A

take by mouth
Under 75: initially 50mg once daily for several weeks then increased to 100mg once daily if necessary.
Over 75: start at 25mg then increase to 100mg if necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications for losartan

A

Patients with low GFR, patients with diabetes mellitus in combination with aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for amlodipine

A

take by mouth, initially 5mg once daily, increased to 10mg once daily if necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications for amlodipine

A

Patients with unstable angina, significant aortic stenosis, or cardiogenic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications for indapamide

A

take by mouth in the morning. 2.5mg daily for immediate release, 1.5mg for modified release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Contraindications for indapamide

A

Patients with electrolyte imbalances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetics of lisinopril

A

oral, 25% bioavailability, 12hr half-life, water soluble, not metabolised in liver, undergoes renal excretion unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetics of losartan

A

oral, 32% bioavailability, 14% converted in first pass metabolism, undergoes CYP450 metabolism, 2hr half-life or 3-9hr half-life for active metabolite, undergoes extensive plasma protein binding, excreted in urine and bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacokinetics of amlodipine

A

oral, 60% bioavailability, 30-50hr half-life, reaches steady state after 7-8 days, slowly metabolised by liver CYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacokinetics of indapamide

A

oral, virtually complete bioavailability, 76-79% protein bound, 16hr half-life, 93% metabolised by liver, excreted in urine and faeces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of lisinopril

A

Dry cough, alopecia, vertigo, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of losartan

A

Postural hypotension, vertigo, vomiting, hyperkalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of amlodipine

A

Headache, peripheral oedema, nausea, tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of indapamide

A

Postural hypotension, electrolyte imbalance, constipation, diarrhoea

17
Q

Hypertension medication pathway if type II diabetes or <55 and not of black or Afro-Caribbean origin

A

ACE or ARB → add CCB or thiazide-like diuretic → combination treatment with ACE/ARB, CCB, and thiazide-like diuretic → if potassium <4.5 mmol/L consider adding spironolactone or if potassium >4.5 mmol/L consider adding alpha or beta blocker

18
Q

Hypertension medication pathway if >55, black or Afro-Caribbean family origin and no type II diabetes

A

CCB → if CCB not tolerated switch to thiazide-like diuretic → add ACE, ARB, or thiazide-like diuretic → combination treatment with ACE/ARB, CCB, and thiazide-like diuretic → if potassium <4.5 mmol/L consider adding spironolactone or if potassium >4.5 mmol/L consider adding alpha or beta blocker

19
Q

ACE inhibitor mechanism of action

A

Bind to and block the angiotensin converting enzyme which blocks the production of angiotensin II

20
Q

ARB mechanism of action

A

antagonists which block the angiotensin II receptors on the kidney

21
Q

Calcium channel blocker mechanism of action

A

Inhibits influx of Ca+ into vascular smooth muscle cells in arteries → reduced levels of Ca+ in muscle cytosol. Level of constriction in arterioles reduced causing vasodilation, reduced total peripheral resistance, and BP

22
Q

Thiazide-like diuretics mechanism of action

A

blocks Na and Cl reabsorption from DCT by blocking Na/Cl symporter. More Na in urine means increased urine volume excreted → reduction in circulating blood volume → reduced BP

23
Q

Potential problems in measuring blood pressure accurately

A

Incorrect cuff size, cuff upside down, unable to identify Korotkoff sounds, caffeine or nicotine use by patients, incorrect patient positioning

24
Q

Define clearance

A

Volume of plasma cleared of drug per unit time

25
Q

What is clearance a significant factor in determining?

A

Limiting time course of drug

26
Q

Define half-life

A

time taken for plasma concentration of drug to halve

27
Q

What is drug half-life useful for?

A

Estimating frequency of dosing

28
Q

Define volume of distribution

A

Proportionality factor that relates the amount of drug in the body to the concentration of drug measured in the plasma

29
Q

What affects volume of distribution?

A

Drug permeability across tissue barriers, plasma protein binding, accumulation in tissues, pH partition

30
Q

What does volume of distribution define?

A

Dose as has an effect on plasma concentration which dictates the ability of a drug to reach its target organ

31
Q

Concentration/time graph for a drug with first order kinetics

A

as time increases, plasma concentration decreases. Shaped like a downwards curve. The fraction eliminated (Kel – the elimination constant) per each unit time is the same. Using a log scale for the plasma concentration results in a straight line with a negative gradient

32
Q

What is first order kinetics?

A

increasing the drug plasma concentration increases the rate of metabolism – metabolic rate is proportional to drug concentration and half-life is constant. Rate of drug elimination increases as the plasma drug concentration increases. This is the case for most drugs at most doses.

33
Q

Describe drugs with short half-lives

A

tend to reach steady state quite rapidly. In general, those with very short half-lives require intravenous infusion to maintain the continued presence of the drug as their effects wear off quickly

34
Q

Describe drugs with long half-lives

A

may take longer to start working but their effects persist for longer, so they may only need to be dosed once a day, once a week, or even less frequently. Chronic dosing (long interval over long time period) used to achieve therapeutic range at steady state.